Atypical hemolytic uremic syndrome (aHUS) is an ultrarare disease caused, in most cases,
by dysregulation of the alternative complement (C′) pathway at the surface of the vascular …

Atypical hemolytic uremic syndrome (aHUS) is characterized by dysregulated complement
activity, the development of a thrombotic microangiopathy (TMA), and widespread end organ …

Background Atypical haemolytic uremic syndrome (aHUS) is a rare but severe form of
thrombotic microangiopathy as a consequence of complement dysregulation. aHUS has a …

Hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia,
thrombocytopenia, and acute renal failure. HUS is classified as either diarrhea associated …

The haemolytic uraemic syndrome (HUS) is characterised by haemolytic anaemia,
thrombocytopenia and acute renal failure. The majority of cases are seen in childhood and …

Le Clech et al. found rare variants in complement genes in only 5% of patients among a
large cohort of secondary hemolytic uremic syndrome cases. The absence of genetic …

Objective: Rare disease Background: Atypical hemolytic uremic syndrome (aHUS) is a rare
disease characterized by hemolysis, thrombocytopenia, and renal dysfunction. It is a …

Atypical hemolytic uremic syndrome (aHUS) is a major thrombotic microangiopathy (TMA). A
TMA is recognized by the laboratory signs of microangiopathic hemolysis, as indicated by …

Plasmatherapy has become empirically first-line treatment in atypical hemolytic uremic
syndrome (aHUS), although no prospective controlled trials have been conducted. Patients …

Atypical hemolytic uremic syndrome (aHUS) is a complementmediated thrombotic
microangiopathy (TMA) characterized by mechanical hemolysis, renal impairment …